Seeking Alpha
Newsletter provider, fund holdings, insider ownership
Profile| Send Message|
( followers)  

Corporate insiders have material non-public information, and they sometimes trade based on such information. Other times they have an edge because they know their companies and industries better than almost all other investors. Therefore, by imitating the insiders, investors are more likely to beat the market.

Here are the 8 healthcare stocks with at least two insider purchases over the past three months. All companies are in the healthcare sector and have at least $2 Billion market cap.

Ticker

Company

YTD

Return

No. of

Insider

Purchases

MRK

Merck & Co. Inc.

-10.83%

2

HGSI

Human Genome Sciences

-40.52%

3

MDT

Medtronic, Inc.

-9.23%

3

MTD

Mettler-Toledo Intl

-7.44%

3

MYL

Mylan, Inc.

-13.44%

3

CELG

Celgene Corporation

5.97%

4

LIFE

Life Technologies

-31.62%

4

VRX

Valeant

34.99%

6

Merck & Co. Inc. (NYSE:MRK): Merck delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. MRK was purchased by two insiders over the past three months and it returned -10.83% since the beginning of this year. It has a market cap of $95.7B and a P/E ratio of 22.5. Ric Dillon invested $173 million in MRK shares.

Human Genome Sciences Inc. (HGSI): Human Genome Sciences is a biopharmaceutical company. HGSI was purchased by three insiders over the past three months and it returned -40.52% since the beginning of this year. It has a market cap of $2.7B. Peter J. Eichler Jr. had $54 million invested in HGSI.

Medtronic, Inc. (NYSE:MDT): Medtronic is engaged in research, design, manufacture and sale of products to alleviate pain, restore health and extend life. MDT was purchased by three insiders over the past three months and it returned -9.23% since the beginning of this year. It has a market cap of $34.9B and a P/E ratio of 11.52. Ken Fisher had $332 million invested in MDT. Ric Dillon and John Paulson also both invested about $200 million in MDT.

Mettler-Toledo International, Inc. (NYSE:MTD): Mettler-Toledo International Inc. is a supplier of precision instruments and services. MTD was purchased by three insiders over the past three months and it returned -7.44% since the beginning of this year. It has a market cap of $4.5B and a P/E ratio of 18.76. Chuck Royce had $40 million invested in MTD shares.

Mylan, Inc. (NASDAQ:MYL): Mylan is a generic and specialty pharmaceutical company. MYL was purchased by three insiders over the past three months and it returned -13.44% since the beginning of this year. It has a market cap of $7.8B and a P/E ratio of 20.55. D. E. Shaw and John Paulson both had about $400 million of MYL shares.

Celgene Corporation (NASDAQ:CELG): Celgene Corporation is a global integrated biopharmaceutical company. CELG was purchased by four insiders over the past three months and it returned 5.97% since the beginning of this year. It has a market cap of $28.8B and a P/E ratio of 28.75. Bain Capital invested over $400 million in CELG.

Life Technologies Corporation (NASDAQ:LIFE): Life Technologies is a global life sciences company. LIFE was purchased by four insiders over the past three months and it lost 31.62% since the beginning of this year. It has a market cap of $6.8B and a P/E ratio of 19.56. Larry Robbins invested $665 million in LIFE shares. John Paulson also had nearly $400 million LIFE stocks.

Valeant Pharmaceuticals International, Inc. (NYSE:VRX): Valeant Pharmaceuticals International is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products.VRX was purchased by six insiders over the past three months and it returned 34.99% since the beginning of this year. It has a market cap of $11.4B. Jeffrey Ubben invested $784 million in VRX shares.

Source: 8 Healthcare Stocks That Insiders Are Bullish About